Physician profile
Nicholas A Grimaldi
NPI 1528080777
$203,346.66
in general payments reported to CMS, 2019-2025
45 companies · $190K in 2025
The $190K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,783 · 2020: $1,460 · 2021: $2,508 · 2022: $2,426 · 2023: $2,464 · 2024: $803 · 2025: $190K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $188K · Royalty Or License: $2,729 · Food and Beverage: $2,138 · Travel and Lodging: $468.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $187,834.10 |
| Royalty Or License | $2,729.39 |
| Food and Beverage | $2,137.61 |
| Travel and Lodging | $467.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philadelphia Medical Management Company LLC | $187,834.10 | 2025 | |
| The Institute of Musculoskeletal Science and Education | $8,711.55 | 2019-2025 | Spira, Fortico |
| Globus Medical, INC. | $1,846.21 | 2019-2025 | Modulus, Acp, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $1,107.73 | 2019-2025 | Mako, Triathlon, Variax |
| Zimmer Biomet Holdings, INC. | $612.87 | 2019-2022 | |
| Zimvie INC. | $322.57 | 2022 | |
| Providence Medical Technology, INC. | $296.55 | 2020-2025 | |
| Intrinsic Therapeutics | $232.68 | 2020-2021 | |
| Pacira Therapeutics, INC. | $228.67 | 2019-2021 | |
| Amgen INC. | $197.43 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbott Laboratories | $171.79 | 2020-2025 | Eterna, Proclaim |
| Spinefrontier, INC. | $162.09 | 2024 | Inspan |
| Boston Scientific Corporation | $124.80 | 2020-2023 | Wavewriter Alpha Prime 16 |
| Cerapedics INC. | $119.36 | 2023-2024 | I-Factor Peptide Enhanced Bone Graft |
| Si-Bone, INC. | $118.37 | 2019-2024 |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $110.38 | 2020-2025 | Vivigen Mis Delivery System, Tfn-Advance |
| Pacira Pharmaceuticals Incorporated | $81.11 | 2022-2023 | Zilretta, Iovera, Exparel |
| Vertex Pharmaceuticals Incorporated | $78.38 | 2024-2025 | |
| Nevro Corp. | $76.99 | 2019-2024 | Senza |
| Smoky Mountain Surgical LLC | $74.86 | 2024 | |
| Medtronic, INC. | $67.23 | 2022-2024 | Intellis Adaptivestim |
| Bioventus LLC | $65.57 | 2020-2023 | Bonescalpel, Exogen Ultrasound Bone Healing System |
| Peerless Surgical INC. | $58.86 | 2025 | |
| Convatec INC. | $51.85 | 2023 | |
| Osteoremedies, LLC | $48.17 | 2025 | Remedy Spectrum Gv Spacer, Remedy Spacer |
| Ethicon US, LLC | $47.79 | 2019-2024 | Enseal X1, Echelon Flex |
| Xtant Medical INC | $47.33 | 2025 | |
| Trice Medical, INC. | $43.91 | 2025 | |
| Organogenesis INC. | $42.48 | 2023-2025 | Puraply, Affinity |
| Heron Therapeutics, INC. | $38.85 | 2025 | Zynrelef |
| Horizon Therapeutics Plc | $37.49 | 2019-2020 | |
| Zavation Medical Products, LLC | $31.78 | 2021 | |
| Nuvasive, INC. | $30.40 | 2022 | |
| Breg, INC | $29.29 | 2021-2023 | Breg Vpulse, Plasmaflow, Polarcarewave |
| Sanara Medtech INC. | $29.27 | 2021-2023 | Celleraterx |
| Zyla Life Sciences, INC. | $25.40 | 2019-2020 | |
| Fidia Pharma USA INC. | $22.45 | 2025 | Triluron, Hymovis |
| Djo, LLC | $21.98 | 2023 | Cmf |
| Arteriocyte Medical Systems, INC. | $17.01 | 2023 | Magellan |
| Camber Spine Technologies LLC | $16.34 | 2023 | |
| Smith+Nephew, INC. | $16.03 | 2025 | Pico |
| Kowa Pharmaceuticals America, INC. | $14.57 | 2023 | Seglentis |
| Kci USA, INC. | $13.10 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $11.64 | 2019 | |
| Kinex Medical Company LLC | $9.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,000,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Grimaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.